Yulia Kipryushina

Dr. Yulia Kipryushina

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
YKYulia Kipryushina
Yulia Kipryushina
KYKonstantin Yakovlev
Konstantin Yakovlev
NONelly A. Odintsova
Nelly A. Odintsova

19 October 2020 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Closed access
PDF file
ABAndrey V. Boroda
Andrey V. Boroda
YKYulia Kipryushina
Yulia Kipryushina
RGRaisa V. Golochvastova
Raisa V. Golochvastova
OSOlga G. Shevchenko
Olga G. Shevchenko
MSMariia Shulgina
Mariia Shulgina
MMMariia Maiorova
Mariia Maiorova

1 December 2013 in Gene Expression Patterns
Verified
Journal Article
Closed access
YKYulia Kipryushina
Yulia Kipryushina
KYKonstantin Yakovlev
Konstantin Yakovlev
MKMilana Kulakova
Milana Kulakova
NONelly A. Odintsova
Nelly A. Odintsova

30 December 2025 in Biology
Verified
Journal Article
Open access
PDF file
MMMariia Maiorova
Mariia Maiorova
YKYulia Kipryushina
Yulia Kipryushina
KYKonstantin Yakovlev
Konstantin Yakovlev
The identification of mRNA isoforms in biological samples is crucial for studying tissue- and cell-specific isoform expression, activity of tissue-specific promoters, alternative splicing events, and alternative polyadenylation signals in genes. For single or several genes, expressed mRNA isoforms can be found using RT-PCR and RT-qPCR. Available transcriptome short-read archives deposited in GenBank or as laboratory data can be used to identify mRNA isoforms instead of or prior to wet analysis by other methods in eukaryotic organisms with annotated genomes. However, isoform expression analysis requires advanced bioinformatics skills and may be time-consuming. In addition, this analysis generates a large amount of unnecessary data. To detect mRNA isoforms encoded by one gene of interest, screening of expressed mRNAs in NGS data can be simplified by mapping NGS short reads to a single-gene or transcript sequence. Using single-gene/transcript mapping, we analyzed the expression of the Otx gene at the mRNA isoform level in some embryonic and adult tissue mRNA libraries of the sea urchin Strongylocentrotus purpuratus available in GenBank. The presence of expressed Otx mRNA isoforms was confirmed by RT-qPCR in the same tissues and at the same developmental stages of the closely related species Strongylocentrotus intermedius. We showed that single-gene/transcript mapping is a suitable approach for qualitative evaluation of the expression of mRNA isoforms and recognition of at least two expressed isoforms in the same biological sample.

25 June 2026 in Pathophysiology
Verified
Journal Article
Open access
PDF file
Igor ManzhuloIgor Manzhulo
Igor Manzhulo
YKYulia Kipryushina
Yulia Kipryushina
ЕГЕкатерина Громова
Екатерина Громова
OMOlga Manzhulo
Olga Manzhulo
EMElena Milkina
Elena Milkina
DIDarya Ivashkevich
Darya Ivashkevich
Background/Objectives. Parkinson’s disease (PD) is a multifactorial neurodegenerative disorder characterized by dopaminergic neuron loss, α-synuclein pathology, neuroinflammation, and cognitive decline. Synaptamide (N-Docosahexaenoylethanolamine (DHEA)) is an endogenous lipid mediator with documented anti-inflammatory and neurogenic properties, but its effects in PD models remain unexplored. This study aimed to evaluate the neuroprotective potential of synaptamide in a subchronic MPTP-induced mouse model of PD. Methods. Male C57BL/6 mice received MPTP (30 mg/kg/day, i.p., 5 days) with or without synaptamide (10 mg/kg/day, s.c., 13 days). Behavioral tests (open field, Y-maze, elevated plus maze, novel object recognition (NOR)) were performed, followed by immunohistochemical analysis of tyrosine hydroxylase (TH)-positive neurons in the substantia nigra, and Western blotting for α-synuclein, p-α-synuclein, TH, and IL1β in brain homogenates and serum. In vitro Neuro-2a cells were co-treated with MPP+ (100 µM) and synaptamide (0.1–10 µM) for cytotoxicity assessment (MTS assay). Results. Synaptamide (10 µM) significantly attenuated MPP+-induced cytotoxicity in Neuro-2a cells. In vivo, MPTP caused a marked loss of TH+-neurons in the substantia nigra, which was prevented by synaptamide treatment. Importantly, this subchronic MPTP model recapitulates early biochemical alterations (e.g., α-synuclein phosphorylation at Ser129) rather than mature Lewy body pathology, a limitation that should be considered when interpreting these findings. Although no motor deficits or anxiety-like behavior were observed, the NOR test revealed MPTP-induced long-term memory impairment, which was fully restored by synaptamide. Conclusions. These findings suggest that synaptamide may exert effects on pathological processes associated with PD, warranting further investigation into its potential role in combination or supportive therapy for this disease.